Back to Hematology
Hematologyv2006Evidence-Based

Geneva Risk Score for Venous Thromboembolism (VTE) Prophylaxis

Predicts the need for venous thromboembolism (VTE) prophylaxis in hospitalized medical patients by assessing risk factors to identify patients who would benefit from thromboprophylaxis versus those at low risk who may not require anticoagulation

Clinical Input Parameters

Clinical Assessment
Awaiting Parameters
geneva vte score
—points
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The Geneva Risk Score for Venous Thromboembolism (VTE) Prophylaxis is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within hematology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

Score = Sum of all risk factors (2 points for major factors: cardiac failure, respiratory failure, recent stroke <3mo, recent MI <4wks, acute infectious disease, acute rheumatic disease, active malignancy, myeloproliferative syndrome, nephrotic syndrome, prior VTE, hypercoagulable state; 1 point for minor factors: immobilization ≥3d, recent travel >6h, age >60y, obesity BMI>30, chronic venous insufficiency, pregnancy, hormonal therapy, dehydration)

Clinical Pearls & Practice Notes

  • Validated in hospitalized medical patients for VTE prophylaxis decision-making
  • Score ≥3 indicates high risk requiring prophylaxis consideration
  • Low-risk patients (score <3) may not require pharmacological prophylaxis
  • Consider contraindications to anticoagulation before starting prophylaxis
  • Mechanical prophylaxis may be used when pharmacological prophylaxis is contraindicated
  • Reassess risk daily during hospitalization as clinical status changes

Evidence & Literature Citations

  1. Chopard P, Spirk D, Bounameaux H. Identifying acutely ill medical patients requiring thromboprophylaxis. J Thromb Haemost. 2006;4(4):915-916. doi: 10.1111/j.1538-7836.2006.01818.x.
  2. Nendaz M, Spirk D, Kucher N, et al. Multicentre validation of the Geneva Risk Score for hospitalised medical patients at risk of venous thromboembolism. Explicit ASsessment of Thromboembolic RIsk and Prophylaxis for Medical PATients in SwitzErland (ESTIMATE). Thromb Haemost. 2014;111(3):531-538. doi: 10.1160/TH13-05-0427.
  3. Decousus H, Tapson VF, Bergmann JF, et al. Factors at admission associated with bleeding risk in medical patients: findings from the IMPROVE investigators. Chest. 2011;139(1):69-79. doi: 10.1378/chest.09-3081.

Score Interpretation Ranges

Low Risk0 – 2 pts

Low risk for VTE

High Risk3 – 33 pts

High risk for VTE

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.